saying Will probably be; intravenous administration appears to be the preferred strategy), then every business utilizing copyright to treat despair or other mental wellness ailments must pay out this “inventor” to work with his “NeonMind’s proprietary preclinical information shows promise that both lower and superior dose psilocybin coul